Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-10

Clinical Trial Update: Cilengitide and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Lung Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating cilengitide in combination with whole-brain radiation therapy for brain metastases arising from lung cancer has been completed. The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • cilengitide (cilengitide)

Snippet

Sponsor: Universitätsmedizin Mannheim | Conditions: Brain and Central Nervous System Tumors, Lung Cancer | Phase 1 | Status: COMPLETED